SPEXOTRAS Trademark

Trademark Overview


On Thursday, November 1, 2018, a trademark application was filed for SPEXOTRAS with the United States Patent and Trademark Office. The USPTO has given the SPEXOTRAS trademark a serial number of 79247604. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, November 14, 2025. This trademark is owned by Novartis AG. The SPEXOTRAS trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
spexotras

General Information


Serial Number79247604
Word MarkSPEXOTRAS
Filing DateThursday, November 1, 2018
Status709 - CANCELLED - SECTION 71
Status DateFriday, November 14, 2025
Registration Number5736664
Registration DateTuesday, April 30, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2019

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 14, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, December 13, 2018SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Saturday, December 15, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 25, 2018APPLICATION FILING RECEIPT MAILED
Thursday, January 3, 2019ASSIGNED TO EXAMINER
Saturday, January 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 23, 2019NOTICE OF PUBLICATION
Wednesday, January 23, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 23, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, February 12, 2019PUBLISHED FOR OPPOSITION
Friday, March 15, 2019NOTIFICATION PROCESSED BY IB
Tuesday, April 30, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, May 30, 2019GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, June 18, 2019FINAL DISPOSITION PROCESSED
Tuesday, June 18, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 23, 2019NOTIFICATION PROCESSED BY IB
Friday, November 14, 2025CANCELLED SECTION 71